NCT05648630View on ClinicalTrials.gov

Improving Exercise Rehabilitation Efficacy Outcomes Veterans Peripheral Artery Disease

NARecruitingINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

July 3, 2023

Primary Completion Date

June 1, 2028

Study Completion Date

June 1, 2028

Conditions
Peripheral Artery Disease (D058729)Oxidative Stress (D018384)Inflammation (D007249)
Interventions
DIETARY_SUPPLEMENT

PB125

PB125 is a naturally-derived plant-based supplement that activates the Nuclear Factor Erythroid-2-like 2 (Nrf2) system to stimulate induction of endogenous antioxidants and anti-inflammatory pathways.

DIETARY_SUPPLEMENT

Placebo

A placebo will be used in combination with exercise rehabilitation allowing for a double blinded placebo controlled design.

BEHAVIORAL

Exercise Rehabilitation

A 12-week treadmill based supervised rehabilitation

Trial Locations (2)

84132

NOT_YET_RECRUITING

University of Utah Dept of Vascular Surgery, Salt Lake City

84148-0001

RECRUITING

VA Salt Lake City Health Care System, Salt Lake City, UT, Salt Lake City

All Listed Sponsors
lead

VA Office of Research and Development

FED